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Abstract
Background: The extracellular calcium-sensing
receptor (CaR) is expressed in many tissues that are
not associated with Ca2+ homeostasis, including the
endocrine cells in pancreatic islets of Langerhans.
We have demonstrated previously that
pharmacological activation of the CaR stimulates
insulin secretion from islet β-cells and insulin-
secreting MIN6 cells. Methods: In the present study
we have investigated the effects of CaR activation
on MIN6 cell proliferation and have used shRNA-
mediated CaR knockdown to determine whether the
CaR is involved in the regulation of insulin secretion
via cell-cell communication. Results: CaR activation
caused the phosphorylation and activation of the p42/
44 MAPK signalling cascade, and this activation was
prevented by the shRNA-induced down-regulation of
CaR mRNA expression. CaR activation also resulted
in increased proliferation of MIN6 cells, consistent with
the known role of the p42/44 MAPK system in the
regulation of β-cell proliferation. Down-regulation of
CaR expression had no detectable effects on glucose-
induced insulin secretion from MIN6 cells maintained
as monolayers, but blocked the increases in insulin
secretion that were observed when the cells were
configured as three-dimensional islet-like structures
(pseudoislets), consistent with a role for the CaR in
cell-cell communication in pseudoislets. Conclusion:
It is well established that islet function is dependent
on communication between islet cells and the results
of this study suggest that the CaR is required for
β-cell to β-cell interactions within islet-like structures.
Introduction
Islets of Langerhans form the minority (<5%) part
of the mammalian pancreas where they comprise small
(100-200μm) clusters of endocrine cells (3000-5000) that
are scattered throughout the exocrine pancreas. Insulin-
expressing β-cells are the majority islet endocrine cell
type (60-70%), but islets also contain glucagon-expressing
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α-cells (10-20%), somatostatin-expressing δ-cells (~5%),
low numbers of ghrelin- and pancreatic polypeptide-
expressing cells, and a variety of non-endocrine cell types
from the vasculature and immune system. Individual islets
are complex functional units which play a crucial role in
regulating glucose homeostasis-loss of β-cells or failure
of their secretory function results in the pathologies
collectively known as diabetes mellitus. The mechanisms
through which individual β-cells recognise and respond
to extracellular signals are fairly well understood, but it is
much less clear how interactions between islet cells
regulate the integrated function of the islet as an endocrine
unit. Intra-islet interactions are known to be essential for
normal function: dispersal of islets into individual cells
results in greatly reduced secretory responsiveness [1]
which can be restored upon reaggregation of the cells
into islet-like structures [1]. There are numerous potential
mechanisms of intra-islet communication, including direct
cell-cell contact via gap-junctions or cell adhesion
molecules, and paracrine interactions via secreted agonists
[2]. The heterogenous composition of a primary islet
facilitates complex interactions between different cell
types [2] but our studies using insulin-expressing MIN6
cells configured as islet-like structures [3, 4] suggest that
homotypic interactions between β-cells are very important
in the regulation of β-cell function. The current study
addresses the possible role of the extracellular Ca2+-
sensing receptor (CaR) in regulating islet function by
acting as an intra-islet mechanism of homotypic
communication between adjacent β−cells.
The CaR is a G-protein-coupled, seven trans-
membrane-spanning domain receptor which enables cells
to detect and respond to changes in extracellular Ca2+
and other divalent cations [5]. CaR expression is
traditionally associated with cells and tissues that are
involved in the regulation of systemic Ca2+ levels, such
as the parathyroid gland, kidney and bone, but it is now
well established that the CaR is also expressed in cells
that are not involved in Ca2+ homeostasis (e.g.
oligodendrocytes [6], breast duct cells [7], fibroblasts [8],
pancreatic acinar cells [9]), where it is associated with
diverse functions including cell proliferation [6-8] and the
regulation of secretion [9]. Our previous studies have
shown that the CaR is expressed by islet β- and α-cells,
but not by δ-cells [10], and that pharmacological activation
of the islet CaR using the calcimimetic A568 results in
enhanced secretion of insulin and glucagon [11], suggesting
an important function for CaR in regulating islet secretory
function. More recently, we have shown that CaR
expression is regulated by the anatomical configuration
of insulin-secreting β-cells, being up-regulated in dispersed
cells, and down-regulated in cells configured as islet-like
clusters (pseudoislets; [12]). It has long been known that
insulin secretory granules contain high concentrations of
divalent cations (Ca2+, Mg2+, Zn2+) that are co-released
with insulin on exocytosis of the granule contents [13],
and these divalent cations may reach sufficient local
extracellular concentrations to activate the CaR [14, 10].
The localised presence within islets of high concentrations
of extracellular cations and the CaR offers a potential
novel mechanism of intra-islet communication. In the
present study we have used shRNA-mediated CaR
knockdown to investigate the role of the CaR in the
regulation of islet function, focusing on β-cell proliferation
and insulin secretion.
Materials and Methods
Insulin-expressing MIN6 cells were obtained from Dr. Y.
Oka and J.-I. Miyazaki (Univ. of Tokyo, Tokyo, Japan). DMEM,
glutamine, penicillin-streptomycin, gelatin (from bovine skin),
PBS, foetal bovine serum and trypsin-EDTA were from Sigma-
Aldrich (Poole, Dorset, U.K.). RNeasy Mini RNA extraction
kits were obtained from Qiagen (Crawley, West Sussex, U.K.).
PCR primers were prepared in-house (Molecular Biology Unit,
King’s College London), and real-time quantitative PCR was
performed using a LightCycler rapid thermal cycler system from
Roche Diagnostics (Burgess Hill, West Sussex, U.K.). The
colorimetric cell proliferation ELISA assay (Roche Diagnostics,
Burgess Hill, West Sussex, U.K.) was used in this study to
quantify cell proliferation. Polyacrylamide gels (10%), molecular
mass markers, sample buffer, and PAGE buffers were from
Invitrogen (Paisley, U.K.). The enhanced chemiluminescence
(ECL) detection system and Hyperfilm were from GE
Healthcare(Buckinghamshire, U.K.). The MEK inhibitors
PD98059 and UO126 were from Calbiochem (Nottingham, UK).
The calcimimetic A568 was from Amgen Inc (Thousand Oaks,
CA, USA). Rabbit polyclonal anti-ACTIVE® MAPK antibody
was from Promega (Southampton, UK), and mouse monoclonal
total p42/44 MAPK antibody was from Transduction
Laboratories (BD Biosciences, Oxford, UK). Horseradish
peroxidase (HRP)-conjugated goat anti-mouse IgG and goat
anti-rabbit IgG were from Pierce Biotechnology (Rockford, IL,
USA). The MISSION™ TRC shRNA kit (Sigma-Aldrich, St
Louis, MO, USA) was used for the downregulation of CaR
using lentiviral vectors.
Cell culture and pseudoislet formation. MIN6 cells were
maintained at 37°C / 5% CO2 in DMEM supplemented with
FBS, penicillin / streptomycin, glutamine and G418, as described
[3]. The medium was changed every 3 days and the monolayers
were passaged or used for experiments when 70% confluent.
MIN6 pseudoislets were generated by culturing MIN6 cells for
7 days on tissue culture flasks that had been precoated with
gelatin, as described previously [3].
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Quantification of CaR mRNA levels
Messenger RNA was isolated from MIN6 cells using the
RNeasy Mini Kit according to the manufacturer’s instructions,
mRNA was quantified using a Nanodrop spectrometer
(NanoDrop, Rockland, ME) and cDNA was synthesised as
described [15]. Mouse CaR forward and reverse PCR primers
were as follows: forward, 5’-CAC TGC GGC TCA TGC TTT
CAC-3’, reverse, 5’-GCC TGG TGT CTG TTC AAA GTG-3’
(amplifies a fragment of 414bp).  Forward and reverse actin
PCR primers were as follows: forward: 5’-ACG GCC AAG TCA
TCA CTA TTG-3’; reverse: 5’-AGC CAC CGA TCC ACA CAG
A-3’, the predicted size of the actin PCR product was 300bp.
CaR standards ranging from 10 copies to 109 copies DNA were
prepared as described [15]. Real-time PCR amplifications were
performed using a LightCycler rapid thermal cycler system in a
10μl volume containing nucleotides, Taq DNA polymerase, and
buffer (all included in the LightCycler FastStart Reaction
Mix SYBR Green I; Roche Diagnostics, Burgess Hill, West
Sussex, U.K ); template cDNA; 5mM MgCl2 and 0.5μM primers.
All PCR protocols included an initial 10 min denaturation step
and each cycle subsequently included a 95°C denaturation for
0s, annealing for 10s at 58°C (actin) or 61°C (CaR), and a 72°C
extension phase for 14s (actin) or 25s (CaR). Fluorescence
measurements were taken at 83°C (actin) or 85°C (CaR) for 3s to
eliminate fluorescence from primer-dimer formation.
The amplification products of both primer pairs were subjected
to melting point analyses and subsequent gel electrophoresis
to ensure specificity of amplification.
Down-regulation of CaR expression in MIN6 cells
The MISSION™ TRC shRNA kit was used to
down-regulate CaR expression in MIN6 cells.
The manufacturers supplied five shRNA constructs targeting
the mouse CaR mRNA, and appropriate control constructs.
The sequences of the shRNA constructs were not supplied.
MIN6 cells were seeded onto 96-well plates ata density of
20,000 cell/well and transduced according to the manufacturer’s
instructions. Clonal selection of transduced cell was by
puromycin (5μg/ml) resistance and expansion over
approximately 30 days. In the current study clones
were expanded after transduction with two CaR shRNA
contructs (CaR2 and CaR4) and  control clones were generated
using lentiviral particles carrying a shRNA construct that
was not directed at the CaR (non-target control), or with
lentiviral particles containing  an empty construct (non-shRNA
control).
MAPK expression and activity
Suspensions of MIN6 cells (1 x106 cells/500μl) were
incubated (37°C, 5 min) in a physiological salt solution in the
presence or absence of 1.3mM CaCl2 or A568 or the MEK
inhibitors PD98059 and UO126. Cells were pelleted by
centrifugation (10000g, 1min), the supernatant was discarded
and protein extracts were prepared as described [11, 16].
Proteins were separated by polyacrylamide gel electrophoresis,
transferred to membranes and immunoprobed for p42/44
MAPK and for phosphorylated (activated) MAPK, as described
[11, 16].
Cell Proliferation
DNA synthesis as a marker of cell proliferation was
assessed by measuring the incorporation of 5-bromo-2’-
deoxyuridine (BrdU) using two methods. Measurements of the
incorporation of BrdU into cell populations used a commercially
available colorimetric assay kit, essentially according to the
manufacturer’s instructions. Briefly, MIN6 cells were seeded
into 96-well microtitre plates at a density of 3,000 cells/well and
were left to adhere overnight in a 37°C/5% CO2 incubator,
followed by overnight incubation in serum-free culture medium
containing 5.5mM glucose. Cells were subsequently incubated
for 2.5 hours in serum-free culture medium containing 5.5mM
glucose in the presence of 10μM BrdU and various
concentrations of test agents. Where the rate of proliferation
was compared between monolayer and pseudoislet
populations, the method was followed as previously described
[17]. Measurements of BrdU incorporation into individual MIN6
cells used a microfluorimetric method to localise BrdU
immunoreactivity in MIN6 cell nuclei, essentially as described
previously [18]. Briefly, MIN6 cells were seeded onto 3-
aminopropyl-triethoxysilane (APES) treated cover glass at a
density of 30,000 cells/well and left to adhere overnight under
standard tissue culture conditions (95% CO2/5%O2 37 °C) in
DMEM supplemented with 15% FCS. Cells were then washed
in sterile PBS and serum starved for 2hrs in fresh DMEM
containing glucose (5.5mM) and nominal calcium (0.25mM)
before a final 3hr incubation in media containing various
concentrations of calcium (0, 0.5 and 2.5mM) and BrdU (10μM).
Cells were fixed with 4% paraformaldehyde and their DNA
denatured using 1M HCl (30min at RT) before incubating in
Alexa-594-conjugated anti-BrdU (Molecular Probes, Invitrogen)
at 1:200 and storing overnight at 4°C. After repeated washing
(PBS /triton (0.01%)) BrdU incorporation was determined using
an Axiovert 200 inverted fluorescent microscope (Carl Zeiss,
Welwyn Garden City, UK). Six different wells were used for
each treatment and the number of BrdU-positive cells counted
in each sample exceeded 100cells/well.
Insulin secretion
Insulin secretion from MIN6 cells and MIN6 pseudoislets
was measured using a multichannel perifusion apparatus
maintained in a 37°C temperature controlled room, as described
previously [19-21]. Perifusate fractions were collected every 2
min and insulin and glucagon content, as appropriate, was
determined by radioimmunoassay [22]. Statistical analysis of
differences between secretory responses used the total areas
under the curves in the perifusion experiments.
Results
CaR down-regulation and coupling
Quantitative RT-PCR analysis of MIN6 cell cDNA
demonstrated the expression of CaR mRNA (Figure 1),
confirming our previous report [12]. The data in Figure 1
also show that the CaR4 shRNA construct caused a
marked down-regulation of CaR mRNA levels in the
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stably-transfected CaR4 MIN6 cell clone, whereas the
CaR2 shRNA construct did not significantly reduce CaR
mRNA expression. The shRNA-induced down-regulation
in CaR mRNA expression resulted in decreased signalling
through the CaR, as shown in Figure 2. In control MIN6
cells the phosphorylation and activation of p42/44 MAPK
was induced by extracellular Ca2+ (1.3mM) in the presence
or absence of the calcimimetic CaR agonist, A568 (0.1μM;
Figure 2 A, B, lanes 3, 4), and this activation was blocked
by the presence of pharmacological inhibitors of MAPK
kinase (MEK; lanes 5,6, PD98059, UO126). In the CaR4
MIN6 cells the stimulatory effects of Ca2+±A568 were
greatly reduced (Fig.2 C, D lanes 3, 4), consistent with a
down-regulation in functional CaR in these cells. The
effect of CaR-downregulation to reduce p42/44
phosphorylation is also apparent in the immunoblots shown
in Figure 2 panels E and F, in which extracts from control
and CaR4 MIN6 cells have been loaded on to adjacent
lanes to allow direct comparisons. The CaR4 MIN6 cell
clone was therefore used for further studies of the effects
of CaR down-regulation on MIN6 cell function.
Fig. 1. Down-regulation of CaR mRNA expression by shRNA.
MIN6 cells were stably transduced with lentiviral particles
containing shRNA constructs against CaR (CaR 2 and CaR 4)
or control constructs (non-shRNA control) and CaR mRNA
expression was measured by quantitative PCR. The CaR4
shRNA induced a marked reduction (P<0.01) in CaR mRNA
compared to non-transduced MIN6 cells (non-transduced
control) or to cells transduced with non-shRNA containing
lentivirus (non-shRNA control). In contrast, the CaR2 shRNA
construct did not induce a significant reduction in CaR mRNA
expression (p>0.2). The results are expressed relative to copy
number for actin mRNA in the same extracts. Data are means +
SEM, n=3. ***p<0.01 vs both control samples. Fig. 2. Decreased signalling through CaR in shRNA CaR4
expressing MIN6 cells. The Figure shows immunoblot analysis
of phosphorylated p42/44 MAPK (A,C,E) and  total
immunoreactive p42/44 MAPK (B,D,F) in control MIN6 cells
(A,B,E,F) or in CaR4-transduced MIN6 cells (C,D,E,F). [A,B]
Incubation of control MIN6 cells in the presence of  Ca2+
(1.3mM) in the absence (lane 3) or presence of 0.1 μM A568
(lane 4) induced a rapid increase in the phosphorylation of
p42/44 MAPK (panel A), that was inhibited by the presence of
the MEK inhibitors PD98059 (50μM) or UO126 (20μM),
consistent with a CaR-dependent activation of p42/44 MAPK.
The membrane was stripped and re-probed with an antibody
against total p42/44 MAPK immunoreactivity (panel B). [C,D]
In CaR4 shRNA transduced cells the effects of Ca2+ in the
absence (lane 3) or presence of 0.1 μM A568 (lane 4) on p42/44
MAPK phosphorylation were much reduced, consistent with
the down-regulation of functional CaR expression in this MIN6
cell clone. Panel D shows total p42/44 MAPK immunoreactivity
in the samples from panel C. Results show one experiment
typical of three. [E,F] These blots show phosphorylated p42/
44 MAPK (E) or total p42/44 (F) in extracts from control MIN6
cells (lanes 1,3,5) or CaR4 MIN6 cells (lanes 2,4,6) to allow
direct comparisons between control and CaR-depleted cells.
The presence of Ca2+ (1.3mM) in the absence (lanes 3,4) or
presence of 0.1 μM A568 (lanes 5,6) induced a rapid increase in
the phosphorylation of p42/44 MAPK in control MIN6 cells
(lanes 3,5), but this was much reduced in CaR4 shRNA
transduced cells (lanes 4,6).
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CaR and MIN6 cell proliferation
The incorporation of BrdU into newly synthesized
DNA was used to assess the effects of experimental
treatments on MIN6 cell proliferation, using two different
methods. Colorimetric measurements of BrdU
incorporation into populations of MIN6 cells give
quantitative estimates of the total DNA synthesis of the
population, but gives no information about the number of
cells in the population which are in a proliferative state.
In contrast microfluorimetric analysis of BrdU
immunostaining does not give quantitative estimates of
changes in the rate of DNA synthesis but does give direct
information on the number of cells in the population which
are actively proliferating. Activation of the CaR by the
calcimimetic A568 [23] in the presence of a physiological
concentration (1.3mM) of extracellular Ca2+ ([Ca2+]o)
stimulated the rate of BrdU incorporation into MIN6
Fig. 3. CaR activation and MIN6 cell proliferation. MIN6 cell
proliferation was assessed by measuring the incorporation of
BrdU into newly-synthesized DNA using an anti-BrdU antibody.
Upper panel: BrdU incorporation into MIN6 populations. MIN6
cells grown as monolayers in 96 well tissue culture plates were
incubated for 2.5 hours in serum-free culture medium containing
5.5mM glucose in the presence of 10μM BrdU and different
concentrations of the calcimimetic A568, as shown. BrdU
incorporation was assessed by colorimetric assay using an
HRP-linked anti-BrdU antibody. Data are expressed as
percentage of the basal BrdU incorporation into cells incubated
in serum-free/5.5mM glucose culture medium, in the absence
of A568. Bars show means+SEM, n=8. *** P<0.01 versus basal
proliferation. The Figure shows one experiment typical of three
separate experiments. Middle panel: BrdU incorporation into
individual MIN6 cells. MIN6 cells grown as monolayers on
glass coverslips were incubated for three hours in medium
containing various concentrations of Ca2+, as shown, with BrdU
(10ìM) being  present for the final two hours of the incubation.
Fluorescence microscopy was used to detect BrdU
incorporation into MIN6 cell DNA using an Alexa 594-
conjugated -conjugated anti-BrdU antibody. A minimum of 100
cells were counted on each coverslip and results are expressed
as the percentage of the total number of cells which showed
positive nuclear immunofluorescence for BrdU. Bars show
mean+SEM for 6 different coverslips. ** P<0.05, *** P<0.01
versus absence of Ca2+. Lower panel: CaR downregulation
reduced proliferation in MIN6 pseudoislets. CaR4-transduced
MIN6 cells showed no changes in BrdU incorporation compared
to control MIN6 cells when grown as monolayers (p>0.2).
However, configuring the CaR4 MIN6 cells as pseudoislets
caused a significant reduction in BrdU incorporation when
compared to control MIN6 cells configured as pseudoislets.
Bars show means+SEM, n=3, ***p<0.01.
monolayer cells (Fig. 3, upper panel). The effects of A568
on MIN6 cell proliferation were not concentration-
dependent, as has also been reported for its  effectson
insulin secretion from islets and MIN6 cells [11],
consistent with A568 acting allosterically to increase the
affinity of the CaR for cations rather than acting as a
direct agonist at the CaR [23]. The presence of [Ca2+]o
alone (0.5 and 2.5mM) also stimulated MIN6 cell
proliferation as assessed by microfluorimetric analysis of
the percentage of the total cell population that incorporated
BrdU (Fig. 3 middle panel), consistent with the [Ca2+]o -
dependent activation of MIN6 cell p42/44 MAPK (Fig.
2) via the CaR. In accordance with these observations,
the A568- and [Ca2+]o-dependent increases in BrdU
incorporation were significantly (P<0.01) reduced by the
presence of the p42/44 MAPK inhibitors PD98059
(50μM; 89±2% control, n=8) or U0126 (20μM; 78±3%
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control, n=8). The shRNA-induced down-regulation of
CaR expression had no detectable effect on the basal
rate of proliferation of MIN6 cells maintained in
monolayer culture. Thus, BrdU incorporation into the
CaR4 MIN6 cell clone was not significantly different from
that of control cells when grown as adherent monolayers
(CaR4 monolayers, 102±4% control, n=3, p>0.2).
However, as shown in Figure 3 (lower panel) reduced
CaR expression had marked effects on BrdU incorporation
when MIN6 cells were configured as pseudoislets, with
CaR4 MIN6 cells showing significantly (p<0.01) reduced
rates of BrdU incorporation when compared to control
MIN6 cells (CaR4 pseudoislets, 49±5% control, n=3,
p<0.01), consistent with a localised intra-islet function of
the CaR that is not apparent when cells are grown as
dispersed monolayers but is revealed when cells are in
close apposition in three-dimensional structures.
CaR and insulin secretion
We have previously demonstrated that
pharmacological activation of the CaR stimulated insulin
secretion from MIN6 cells and from primary β-cells [11-
12]. The measurements of insulin secretion shown in
Fig. 4. Effects of CaR down-regulation on insulin secretion.
Upper panel: Effect of cell configuration on insulin secretion
Control (non-shRNA vector transduced) MIN6 cells configured
as monolayers (   ) or as pseudoislets (   ) were perifused with
buffer containing 2mM glucose for 10 minutes (0-10 min) to
achieve a basal rate of secretion, after which they were exposed
to a buffer containing 20mM glucose. Cells configured as
pseudoislets showed significantly (p<0.001) enhanced
secretory responses when compared to equivalent cells
maintained as monolayers. Secretion is expressed as a
percentage of basal (2mM glucose) secretion. Points show
means ± SEM, n=4, and statistical analysis compares areas
under the curves between groups. Lower panel: Effects of CaR
down-regulation on insulin secretion from pseudoislets.
Pseudoislets formed from control (   ) or CaR-depleted (   ) CaR4
MIN6 cells were perifused with buffer containing 2mM glucose
for 10 minutes (0-10 min), after which they were exposed to a
buffer containing 20mM glucose. Insulin secretion from the
CaR4 pseudoislets was significantly less (p<0.001) than from
control pseudoislets, Secretion is expressed as a percentage of
basal (2mM glucose) secretion. Points show means ± SEM,
n=4.
Figure 4 (upper panel) demonstrate that configuring
control MIN6 cells as three-dimensional pseudoislets
caused enhanced insulin secretory responses to glucose
over those of equivalent cells grown as monolayers,
confirming our previous observations [1-3]. Thus, the
MIN6 cells grown as pseudoislets consistently showed a
peak glucose-induced (20mM) insulin secretory response
of approximately 300% over basal (2mM), while the
maximum response of monolayer cells was an
approximately 80% increase. The reduced expression of
the CaR in CaR4 MIN6 cells had no significant effect on
insulin secretion when the cells were grown as
monolayers (CaR4 monolayers, 148±23% control, n=4,
p>0.1). However, reduced CaR expression was
associated with reduced glucose-induced insulin secretion
when the cells were configured as pseudoislets, as shown
in Figure 4 (lower panel) which compares the insulin
secretory responses of pseudoislets formed from control
MIN6 cells with those formed from CaR4 MIN6 cells.
The role of the CaR in insulin secretion from pseudoislets
was further investigated by exposing glucose-stimulated
(20mM) pseudoislets to KCl (20mM) as a directly-
depolarising stimulus, in contrast to glucose which is
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dependent upon glycolytic metabolism. When expressed
relative to the maximum glucose-induced (20mM)
secretory response there was no significant difference in
KCl-induced insulin secretion between pseudoislets
formed from control MIN6 cells or those formed from
CaR-deficient CaR4 MIN6 cells (control pseudoislets,
165±4% increase; CaR4 pseudoislets 179±8%, n=4,
p>0.1).
Discussion
The CaR is now known to be expressed in cell types
which are not involved in systemic Ca2+ homeostasis,
suggesting that its prime function in these cells is
something other than the detection of circulating Ca2+ [6-
8, 24, 25]. One alternative function for the CaR may be
to detect and respond to localized rather than systemic
changes in [Ca2+]o and the CaR has been implicated in
the detection of Ca2+ concentrations in pancreatic juice
[9] and the intestinal lumen [26], and as a mechanism
through which neuronal cells are influenced by the
electrical activity of their near neighbours via local changes
in [Ca2+]o [27]. We have reported previously that
pancreatic endocrine cells express the CaR [10, 11], and
that its pharmacological activation stimulates secretion
of insulin and glucagon [11, 12]. The aim of the current
study was to determine whether the β-cell CaR is
involved in intra-islet cell-cell communication by detecting
the localized release of divalent cations that are stored in
β-cell secretory granules and co-released with insulin [13].
The obvious experimental approach of depleting insulin
secretory granules of their cation content was not feasible
because this causes a failure of secretory vesicle
formation and disrupts the secretory process [28]. The
alternative approach of using extracellular chelators to
sequester secreted cations was also not feasible because
an influx of [Ca2+]o is essential for normal insulin
secretion. We therefore adopted the strategy of
manipulating β-cell CaR and, in the absence of
commercially-available, selective CaR antagonists, we
used shRNA-mediated RNA interference to manipulate
CaR expression. Primary islets are heterogenous organs
[2] and studies of cell-cell interactions are complicated
by numerous interactions between the different islet cell
types [2]. We have therefore developed methods to
generate islet-like structures (pseudoislets) from the MIN6
mouse insulin-secreting cell line [29] as a simple and well-
defined model in which to study homotypic β-cell
interactions [1-4, 17]. MIN6 cells have the additional
advantage over primary β-cells of being amenable to
transduction and selection which facilitated the generation
of stable CaR under-expressing cell lines, such as the
CaR4 MIN6 cells used in the present study. The reduced
expression of CaR mRNA in these cells was
accompanied by reduced functional activity of the CaR,
as assessed by p42/44 MAPK activation, thus validating
CaR4 MIN6 cells as a useful model for studying CaR
involvement in β-cell function.
CaR activation has been associated with increased
proliferation in a variety of cell types, including fibroblasts
[8], astrocytoma cells [30], and osteoblasts [31], and our
results are consistent with a role for the CaR in the
regulation of β-cell proliferation. There are technical
difficulties associated with measurements of β-cell
proliferation in primary islets, largely because of the very
low mitotic index of primary β-cells in adult islets, and
MIN6 cells have been used as substitutes in several studies
of β-cell proliferation [18, 32-34]. Proliferative MIN6 cells
constitutively over-express the SV40 large T antigen [29]
which de-regulates their cell cycle [29]. However, the
results of the current study and previous studies [34, 35]
demonstrate that at least part of the MIN6 cell
proliferative capacity is regulated by extracellular signals,
validating this experimental model. In the present study,
pharmacological activation of the CaR stimulated MIN6
cell proliferation and this was due, at least in part, to an
increase in the number of cells in the proliferative state.
The CaR-induced increase in MIN6 cell proliferation was
associated with activation of the p42/44 MAPK pathway
which has been implicated in cell-cycle regulation in a
wide variety of mammalian tissues [38-40], including
MIN6 cells [18]. Our results demonstrated that the
presence of [Ca2+]o was alone sufficient to activate p42/
44 MAPK and enhance MIN6 cell proliferation,
consistent with reports in other cell types that elevated
[Ca2+]o can activate p42/44 [36] and increase cell
proliferation [37]. The current results also show that
further pharmacological activation of CaR using an
allosteric activator (A568) enhanced MIN6 cell
proliferation at a physiological concentration of [Ca2+]o.
The involvement of p42/44 MAPK in transducing signals
from the β-cell CaR was confirmed by the inhibitory
effects of two pharmacological agents, PD98059 and
UO126, both of which inhibit the activity of the mitogen-
activated ERK-activating kinase (MEK) which is
upstream of the p42/44 MAPKs. These observations are
consistent with our previous report that CaR-dependent
stimulation of insulin secretion from MIN6 pseudoislets
was associated with the activation of p42/44 MAPK and
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was inhibited by the presence of MEK inhibitors [11],
and suggest that transduction through p42/44 MAPK
cascade is central to the effects of CaR activation on
β-cell  function.
The reduced levels of CaR expression in CaR4 MIN6
cells did not influence their proliferative capacity when
the cells were grown as monolayers, suggesting that the
levels of CaR expression per se do not affect the growth
rate of MIN6 cells. However, the CaR-depleted cells
showed significantly reduced rates of proliferation when
configured as pseudoislets, consistent with signalling
through the CaR being involved in the regulation of β-cell
proliferation in situations where the cells are sufficiently
close to communicate by localized release of an
endogenous CaR activator (i.e. pseudoislets), but not
where the cells are anatomically separate (i.e.
monolayers). Thus, the current studies of CaR
involvement in β-cell proliferation are consistent with a
model in which β-cells within islet-like structures influence
neighbouring β-cells by releasing an endogenous activator
of the CaR (Ca2+, other divalent cations) which increases
the proliferative capacity of neighbouring β-cells through
CaR activation of the p42/44 MAPK cascade.
The physiological significance of this proposed mechanism
is uncertain, but the β-cell mass increases at times of
increased demand for insulin [41, 42], and CaR activation
by divalent cations co-released with insulin offers one
mechanism through which β-cells can monitor their own
secretory activity (autocrine) and that of neighbouring
β-cells (paracrine) and adjust their proliferative potential
accordingly.
The results of this study also suggest an important
role for the β-cell CaR in integrating the secretory
responses of β-cells in islet-like structures. Thus,
insulin secretion from individual MIN6 cells was not
affected by manipulating the levels of CaR expression,
suggesting that CaR expression is not an important
regulator of signal recognition in β-cells. However,
previous studies have shown that CaR activation is alone
sufficient to trigger insulin secretion [11, 12], and our
experiments demonstrated that down-regulation of CaR
expression prevented the improvement of insulin secretory
responses when MIN6 cells were configured as islet-
like structures, consistent with CaR activation being an
important  means of intra-islet communication. Individual
β-cells  are heterogenous and differ in their sensory [43],
biosynthetic [44, 45], intracellular Ca2+ [21] and secretory
[46] responses to external stimuli. CaR activation
by secreted cations offers one mechanism through which
an activated β-cell could activate less-sensitive
neighbouring cells, and thus enable a heterogenous
population of cells to mount an integrated response to
external signals [2]. A recruiting role for the CaR
in  islet-like structures is further supported by our
observation that CaR down-regulation had no effect on
secretory responses of MIN6 pseudoislets to high
extracellular  K+, a stimulus that bypasses normal
metabolic processes and directly activates all the
pseudoislet cells.
In conclusion, it is well established that normal
islet function is dependent on communication between
islet cells [2] and the results of this study suggest
that β-cell to β-cell interactions via the CaR are
one mechanism of this communication.
Acknowledgements
This work was supported by grants from
Diabetes UK (BDA:RD05/0003080) and the Eli Lilly
International Foundation. IKM was supported by a
MRC postgraduate studentship.
References
1 Luther MJ, Hauge-Evans A, Souza K,
Jörns A, Lenzen S, Persaud SJ, Jones PM:
MIN6 b-cell-b-cell interactions influence
insulin secretory responses to nutrients
and non-nutrients. Biochemical and
Biophysical Research Communications
2006;343:99-104.
2 Carvell MJ, Persaud SJ, Jones PM: An
islet is greater than the sum of its parts:
the importance of intercellular
communication in insulin secretion.
Cellscience Reviews 2006;3:100-128.
3 Hauge-Evans AC, Squires PE, Persaud SJ,
Jones PM: Pancreatic beta-cell-to-beta-
cell interactions are required for integrated
responses to nutrient stimuli: enhanced
Ca2+ and insulin secretory responses of
MIN6 pseudoislets. Diabetes
1999;48:1402-1408.
Kitsou-Mylona/Burns/Squires/Persaud/JonesCell Physiol Biochem 2008;22:557-566
565
4 Brereton HC, Carvell MJ, Asare-Anane
H, Roberts G, Christie MR, Persaud SJ,
Jones PM: Homotypic cell contact
enhances insulin but not glucagon
secretion. Biochemical and Biophysical
Research Communications
2006;344:995-1000.
5 Brown EM and MacLeod R: Extracellular
Calcium Sensing and Extracellular
Calcium Signaling. Physiol Rev
2001;81:239-297.
6 Chattopadhyay N, Ye CP, Yamaguchi T,
Kifor O, Vassilev PM, Nishimura R,
Brown EM: Extracellular calcium-
sensing receptor in rat oligodendrocytes:
expression and potential role in
regulation of cellular proliferation and
an outward K+ channel. Glia
1998;24:449-458.
7 Cheng I, Klingensmith ME,
Chattopadhyay N, Kifor O, Butters RR,
Soybel DI, Brown EM: Identification and
Localization of the Extracellular
Calcium-Sensing Receptor in Human
Breast. J Clin Endocrinol Metab
1998;83:703-707.
8 McNeil SE, Hobson SA, Nipper V, Rodland
KD: Functional Calcium-sensing
Receptors in Rat Fibroblasts Are Required
for Activation of SRC Kinase and
Mitogen-activated Protein Kinase in
Response to Extracellular Calcium. J Biol
Chem 1998;273:1114-1120.
9 Bruce JIE, Yang X, Ferguson CJ, Elliott
AC, Steward MC, Maynard Case R,
Riccardi D: Molecular and functional
identification of a Ca2+ (polyvalent
cation)-sensing receptor in rat pancreas.
J Biol Chem 1999;20561-20568.
10 Squires PE, Harris TE, Persaud SJ, Curtis
SB, Buchan AM, Jones P: The
extracellular calcium-sensing receptor on
human beta-cells negatively modulates
insulin secretion. Diabetes 2000;49:409-
417.
1 1 Gray E, Muller D, Squires PE, Asare-
Anane H, Huang G, Amiel S, Persaud SJ,
Jones PM: Activation of the extracellular
calcium-sensing receptor initiates insulin
secretion from human islets of
Langerhans: involvement of protein
kinases. J Endocrinol 2006;190:703-710.
12 Jones PM, Kitsou-Mylona I, Gray E,
Squires PE, Persaud SJ: Expression and
function of the extracellular calcium-
sensing receptor in pancreatic Î²-cells.
Archives Of Physiology And
Biochemistry 2007;113:98-103.
13 Hutton J: The insulin secretory granule.
Diabetologia 1989;32:271-281.
14 Perez-Armendariz E and Atwater I:
Glucose-evoked changes in [K+] and
[Ca2+] in the intercellular spaces of the
mouse islet of Langerhans. Advances in
Experimental Medicine and Biology
1986;211:31-51.
15 Persaud SJ, Roderigo-Milne HM, Squires
PE, Sugden D, Wheeler-Jones C, Marsh
PJ, Belin VD, Luther MJ, Jones PM: A
Key Role for {beta}-Cell Cytosolic
Phospholipase A2 in the Maintenance
of Insulin Stores But Not in the Initiation
of Insulin Secretion. Diabetes
2002;51:98-104.
16 Gyles SL, Burns CJ, Whitehouse BJ,
Sugden D, Marsh PJ, Persaud SJ, Jones
PM: ERKs Regulate Cyclic AMP-induced
Steroid Synthesis through Transcription
of the Steroidogenic Acute Regulatory
(StAR) Gene. J Biol Chem
2001;276:34888-34895.
17 Luther MJ, Davies E, Muller D, Harrison
M, Bone AJ, Persaud SJ, Jones PM: Cell-
to-cell contact influences proliferative
marker expression and apoptosis in MIN6
cells grown in islet-like structures. Am J
Physiol Endocrinol Metab
2005;288:E502-E509.
18 Burns CJ, Squires PE, Persaud SJ:
Signaling through the p38 and p42/44
Mitogen-Activated Families of Protein
Kinases in Pancreatic [beta]-Cell
Proliferation. Biochemical and
Biophysical Research Communications
2000;268:541-546.
19 Jones PM, Persaud SJ, Howell SL: Time-
course of Ca2+-induced insulin secretion
from perifused, electrically permeabilised
islets of Langerhans: effects of cAMP
and a phorbol ester. Biochemical and
Biophysical Research Communications
1989;162:998-1003.
20 Hauge-Evans A, Squires P, Belin V,
Roderigo-Milne H, Ramracheya R,
Persaud S, Jones P: Role of adenine
nucleotides in insulin secretion from
MIN6 pseudoislets. Molecular and
Cellular Endocrinology 2002;191:167-
176.
21 Squires P, Persaud S, Hauge-Evans A, Gray
E, Ratcliff H, Jones P: Co-ordinated
Ca2+-signalling within pancreatic islets:
does [beta]-cell entrainment require a
secreted messenger. Cell Calcium
2002;31:209-219.
22 Jones P, Salmon D, Howell S: Protein
phosphorylation in electrically
permeabilized islets of Langerhans.
Effects of Ca2+, cyclic AMP, a phorbol
ester and noradrenaline. Biochem J
1988;254:397-403.
23 Nemeth EF, Steffey ME, Hammerland
LG, Hung BCP, Van Wagenen BC, DelMar
EG, Balandrin MF: Calcimimetics with
potent and selective activity on the
parathyroid calcium receptor.
Proceedings of the National Academy of
Sciences of the United States of America
1998;95:4040-4045.
24 Hobson SA, McNeil SE, Lee F, Rodland
KD: Signal Transduction Mechanisms
Linking Increased Extracellular Calcium
to Proliferation in Ovarian Surface
Epithelial Cells. Experimental Cell
Research 2000;258:1-11.
25 Tu CL, Chang W, Bikle DD: The
Extracellular Calcium-sensing Receptor
Is Required for Calcium-induced
Differentiation in Human Keratinocytes.
J Biol Chem 2001;276:41079-41085.
26 Ray JM, Squires PE, Curtis SB, Meloche
MR, Buchan AM: Expression of the
calcium-sensing receptor on human antral
gastrin cells in culture. Journal of Clinical
Investigation 1997;99:2328-2333.
27 Hofer AM, Curci S, Doble MA, Brown
EM, Soybel DI: Intercellular
communication mediated by the
extracellular calcium-sensing receptor.
Nat Cell Biol 2000;2:392-398.
28 Cheng H, Beck A, Launay P, Gross SA,
Stokes AJ, Kinet JP, Fleig A, Penner R:
TRPM4 controls insulin secretion in
pancreatic [beta]-cells. Cell Calcium
2007;41:51-61.
29 Miyazaki J, Araki K, Yamato E, Ikegami
H, Asano T, Shibasaki Y, Oka Y,
Yamamura K: Establishment of a
pancreatic beta cell line that retains
glucose- inducible insulin secretion:
special reference to expression of glucose
transporter isoforms. Endocrinology
1990;127:126-132.
30 Chattopadhyay N, Ye CP, Yamaguchi T,
Kerner R, Vassilev PM, Brown EM:
Extracellular calcium-sensing receptor
induces cellular proliferation and
activation of a nonselective cation
channel in U373 human astrocytoma
cells. Brain Research 1999;851:116-124.
31 Huang Z, Cheng SL, Slatopolsky E:
Sustained Activation of the Extracellular
Signal-regulated Kinase Pathway Is
Required for Extracellular Calcium
Stimulation of Human Osteoblast
Proliferation. J Biol Chem
2001;276:21351-21358.
32 Tanabe K, Okuya S, Tanizawa Y,
Matsutani A, Oka Y: Leptin Induces
Proliferation of Pancreatic [beta] Cell
Line MIN6 through Activation of
Mitogen-Activated Protein Kinase.
Biochemical and Biophysical Research
Communications 1997;241:765-768.
33 Yoshitomi H, Fujii Y, Miyazaki M,
Nakajima N, Inagaki N, Seino S:
Involvement of MAP kinase and c-fos
signaling in the inhibition of cell growth
by somatostatin. Am J Physiol
Endocrinol Metab 1997;272:E769-
E774.
34 Muller D, Jones PM, Persaud SJ:
Autocrine anti-apoptotic and
proliferative effects of insulin in
pancreatic [beta]-cells. FEBS Letters
2006;580:6977-6980.
Calcium Sensing Receptor and Pancreatic β-cell Function Cell Physiol Biochem 2008;22:557-566
566
35 Carvell MJ, Marsh PJ, Persaud SJ, Jones
PM: E-cadherin interactions regulate â-
cell proliferation in islet-like structures.
Cellular Physiology and Biochemistry
2008;20:617-626.
3 6 Sakwe AM, Larsson M, Rask L:
Involvement of protein kinase C-alpha
and -epsilon in extracellular Ca2+
signalling mediated by the calcium sensing
receptor. Experimental Cell Research
2004;297:560-573.
3 7 Liao J, Schneider A, Datta NS, McCauley
LK: Extracellular Calcium as a Candidate
Mediator of Prostate Cancer Skeletal
Metastasis. Cancer Res 2006;66:9065-
9073.
38 Ahn NG, Weiel JE, Chan CP, Krebs EG:
Identification of multiple epidermal
growth factor-stimulated protein serine/
threonine kinases from Swiss 3T3 cells.
J Biol Chem 1990;265:11487-11494.
39 Pagès G, Lenormand P, L’Allemain G,
Chambard JC, Meloche S, Pouysségur J:
Mitogen-activated protein kinases
p42mapk and p44mapk are required for
fibroblast proliferation. Proceedings of
the National Academy of Sciences of the
United States of America 1993;90:8319-
8323.
40 Conejo R and Lorenzo M: Insulin
signalling leading to proliferation,
survival and membrane ruffling in C2C12
myoblasts. Journal of Cellular Physiology
2008;187:96-108.
41 Parsons JA, Brelje TC, Sorenson RL:
Adaptation of islets of Langerhans to
pregnancy: increased islet cell
proliferation and insulin secretion
correlates with the onset of placental
lactogen secretion. Endocrinology
1992;130:1459-1466.
42 Vinink A, Pittenger G, Rafaeloff R,
Rosenberg L, Duguid W: Determinants
of pancreatic islet mass: a balance
between neogenesis and senescence/
apoptosis. Diabetes Rev 1996;4:235-
263.
43 Kiekens R, In’t Veld P, Mahler T, Schuit
F, Van De Winkel M, Pipeleers D:
Differences in glucose recognition by
individual rat pancreatic B cells are
associated with intercellular differences
in glucose-induced biosynthetic activity.
Journal of Clinical Investigation
1992;89:117-125.
44 Schuit FC, In’t Veld PA, Pipeleers DG:
Glucose stimulates proinsulin
biosynthesis by a dose-dependent
recruitment of pancreatic beta cells.
Proceedings of the National Academy of
Sciences of the United States of America
1988;85:3865-3869.
45 Bosco D and Meda P: Reconstructing islet
function in vitro. Advances in
Experimental Medicine and Biology
1997;426:285-298.
46 Stefan Y, Meda P, Neufeld M, Orci L:
Stimulation of insulin secretion reveals
heterogeneity of pancreatic B cells in
vivo. Journal of Clinical Investigation
1987;80:175-183.
Kitsou-Mylona/Burns/Squires/Persaud/JonesCell Physiol Biochem 2008;22:557-566
